Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学HCC, Adjuvant/Local Therapy

Talia Golan

MD

🏢Sheba Medical Center🌐Israel

Associate Professor of Oncology

41
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Talia Golan specializes in hepatobiliary cancers including cholangiocarcinoma adjuvant and systemic strategies, contributing to trials examining gemcitabine-cisplatin-based combinations and immunotherapy for biliary tract cancers. Her research addresses emerging adjuvant strategies in resected cholangiocarcinoma, examining FGFR2 and IDH1 targeted therapies as post-resection options. She has led translational research on BRCA and HRD status in biliary tract cancers. Golan contributes to international guidelines for hepatopancreaticobiliary cancer management.

Share:

🧪Research Fields 研究领域

cholangiocarcinoma adjuvant therapy
biliary tract cancer KEYNOTE-966
intrahepatic cholangiocarcinoma IDH
FGFR2 cholangiocarcinoma adjuvant
HER2 biliary tract cancer

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Talia Golan 的研究动态

Follow Talia Golan's research updates

留下邮箱,当我们发布与 Talia Golan(Sheba Medical Center)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment